Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID‐19 Pandemic

Documenti analoghi

• Trends in prescription opioid use in Europe: A DARWIN EU® multinational cohort study including seven European countries
  di: Xie, JQ, et al.
  Pubblicazione: (2025)
• Secular Trends in the Use of Valproate-Containing Medicines in Women of Childbearing Age in Europe: A Multinational DARWIN EU Network Study
  di: Bellas, L, et al.
  Pubblicazione: (2025)
• Standardised and Reproducible Phenotyping Using Distributed Analytics and Tools in the Data Analysis and Real World Interrogation Network (DARWIN EU)
  di: Francesco Dernie, et al.
  Pubblicazione: (2024)
• Hydroxychloroquine Patch Test Positivity in a Patient With Systemic Lupus Erythematosus
  di: Alexa G. Ries, et al.
  Pubblicazione: (2026)
• Hydroxychloroquine and Pre‐eclampsia in a Diverse Cohort of Women With Systemic Lupus Erythematosus
  di: Julia F. Simard, et al.
  Pubblicazione: (2024)